Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
J Orthop Surg (Hong Kong) ; 24(1): 22-6, 2016 04.
Article in English | MEDLINE | ID: mdl-27122507

ABSTRACT

PURPOSE: To compare cup-positioning accuracy in total hip arthroplasty (THA) with or without use of a Kirschner wire as a transverse-axis guide for pelvic alignment. METHODS: Records of 18 men and 73 women (mean age, 60 years) who underwent primary THA with (n=49) or without (n=42) use of a Kirschner wire as a transverse-axis guide for pelvic alignment were reviewed. A 2.4-mm Kirschner wire as a transversea-xis guide was inserted to the anterior superior iliac spine and was parallel to a line linking the left and right anterior superior iliac spine. The safe zone for cup positioning was defined as 30º to 50° abduction and 10º to 30º anteversion. Of the 5 operative surgeons, 2 were classified as experienced (total surgical volume >300) and 3 as inexperienced (total surgical volume of <50). The proportion of patients with the cup in the safe zone was compared in patients with or without use of the transverse-axis guide and in experienced and inexperienced surgeons. RESULTS: For inexperienced surgeons, the use of the transverse-axis guide significantly improved the proportion of patients with the cup in the safe zone from 90% to 100% for abduction, from 50% to 82.4% for anteversion, and from 40% to 82.4% for both. Patients with the cup inside or outside the safe zone were comparable in terms of body height, weight, BMI, subcutaneous fat thickness, incision length, and acetabular cup size. CONCLUSION: The use of the transverse-axis guide improved the accuracy of cup positioning by inexperienced surgeons.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Bone Wires , Hip Prosthesis , Acetabulum/surgery , Adult , Aged , Female , Humans , Male , Middle Aged , Patient Positioning , Range of Motion, Articular , Retrospective Studies
2.
Br J Cancer ; 112(7): 1232-40, 2015 Mar 31.
Article in English | MEDLINE | ID: mdl-25742474

ABSTRACT

BACKGROUND: Activation of the Notch pathway has been reported in various types of cancers. However, the role of the hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) in osteosarcoma is unknown. We examined the function of HEY1 in osteosarcoma. METHODS: Expression of HEY1 was studied in human osteosarcoma. The effects of HEY1 in osteosarcoma were evaluated in vitro and in a xenograft model. Moreover, we examined the function of matrix metallopeptidase 9 (MMP9) as a downstream effector of HEY1. RESULTS: HEY1 was upregulated in human osteosarcoma. Knockdown of HEY1 inhibited the invasion of osteosarcoma cell lines. In contrast, the forced expression of HEY1 increased the invasion of mesenchymal stem cell. In addition, lung metastases were significantly inhibited by the knockdown of HEY1. We found that MMP9 was a downstream effector of HEY1 that promotes the invasion of osteosarcoma cells. Knockdown of HEY1 decreased the expression of MMP9. Addition of MMP9 rescued the invasion of osteosarcoma cells that had been rendered less invasive by knockdown of HEY1 expression. CONCLUSIONS: Our findings suggested that HEY1 augmented the metastasis of osteosarcoma via upregulation of MMP9 expression. Therefore, inhibition of HEY1 may be a novel therapeutic strategy for preventing osteosarcoma metastasis.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Cell Cycle Proteins/metabolism , Matrix Metalloproteinase 9/biosynthesis , Osteosarcoma/metabolism , Osteosarcoma/pathology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Bone Neoplasms/enzymology , Bone Neoplasms/genetics , Cell Cycle Proteins/genetics , Cell Line, Tumor , Gene Knockdown Techniques , Heterografts , Humans , Lung Neoplasms/enzymology , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lung Neoplasms/secondary , Matrix Metalloproteinase 9/genetics , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/pathology , Mice , Mice, Nude , Neoplasm Metastasis , Osteosarcoma/enzymology , Osteosarcoma/genetics , Signal Transduction , Transfection , Up-Regulation
3.
Oral Dis ; 16(7): 702-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20561223

ABSTRACT

AIM: The purpose of this study was to evaluate the association between oral malodour and periodontal disease, and to determine the effect of periodontal therapy on oral malodour. MATERIALS AND METHODS: Oral malodour parameters, including volatile sulphur compound (VCS) measurement, methyl mercaptan/hydrogen sulphide ratio by gas chromatography, organoleptic testing, tongue coating score, and periodontal parameters were evaluated in 823 patients complaining of oral malodour. Amongst these patients, 89 with oral pathogenic halitosis received tongue cleaning and periodontal therapy. Oral malodour and periodontal parameters were measured at baseline and after treatment. RESULTS: Amongst 823 patients, 102 were diagnosed with gingivitis and 721 with periodontitis. VCS levels and periodontal parameters increased according to the severity of oral malodour. Organoleptic testing significantly correlated with periodontal probing depth and a percentage of periodontal pocket depth ≥4mm (r=0.40 and 0.39 respectively). There were significant correlations between methyl mercaptan/hydrogen sulphide ratio and periodontal parameters. Significant decrease in oral malodour and periodontal parameters in 89 patients with oral pathogenic halitosis was also observed after periodontal treatment. CONCLUSIONS: Oral malodour is associated with periodontal disease, and periodontal therapy combined with tongue cleaning is beneficial for oral pathogenic halitosis.


Subject(s)
Halitosis/complications , Periodontal Diseases/complications , Adult , Chromatography, Gas , Dental Plaque Index , Dental Scaling , Female , Gingival Hemorrhage/complications , Gingival Hemorrhage/metabolism , Gingival Hemorrhage/therapy , Gingivitis/complications , Gingivitis/metabolism , Gingivitis/therapy , Halitosis/metabolism , Halitosis/therapy , Humans , Hydrogen Sulfide/analysis , Japan , Male , Middle Aged , Oral Hygiene , Periodontal Diseases/metabolism , Periodontal Diseases/therapy , Periodontal Index , Periodontal Pocket/complications , Periodontal Pocket/metabolism , Periodontal Pocket/therapy , Periodontitis/complications , Periodontitis/metabolism , Periodontitis/therapy , Root Planing , Smell , Sulfhydryl Compounds/analysis , Sulfides/analysis , Tongue/pathology , Volatile Organic Compounds/analysis
4.
Br J Cancer ; 101(12): 2030-7, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-19888223

ABSTRACT

BACKGROUND: The hypothesis that malignant tumours are generated by rare populations of cancer stem cells that are more tumourigenic than other cancer cells has gained increasing credence. The objective of this study was to identify and characterise a subpopulation of human sarcoma-initiating cells. METHODS: We examined established rhabdomyosarcoma cell lines by flow cytometry. Tumourigenesis was examined by xenograft models. Real-time PCR and immunohistochemistry were performed to examine the gene expression using cell lines and biopsy specimens. RESULTS: Rhabdomyosarcoma cell lines included small populations of fibroblast growth factor receptor 3 (FGFR3)-positive cells. FGFR3-positive KYM-1 and RD cells were more strongly tumourigenic than FGFR3-negative cells. In addition, xenoengraftment of 33% of single FGFR3-positive KYM-1 cells yielded tumour formation. Stem cell properties of FGFR3-positive cells were further established by real-time PCR, which demonstrated upregulation of undifferentiated cell markers and downregulation of differentiation markers. We showed that in the absence of serum, addition of basic fibroblast growth factor maintained and enriched FGFR3-positive cells. On the other hand, ciliary neurotrophic factor reduced the proportion of FGFR3-positive cells. Real-time PCR and immunohistochemical examination revealed that embryonal rhabdomyosarcoma patient biopsy specimens were found to over-express FGFR3. CONCLUSIONS: Our findings suggest that rhabdomyosarcoma cell lines include a minor subpopulation of FGFR3-positive sarcoma-initiating cells, which can be maintained indefinitely in culture and which is crucial for their malignancy.


Subject(s)
Neoplastic Stem Cells/pathology , Receptor, Fibroblast Growth Factor, Type 3/physiology , Rhabdomyosarcoma/pathology , Animals , Biopsy , Cell Differentiation , Cell Line, Tumor , Flow Cytometry , Humans , Mice , Receptor, Fibroblast Growth Factor, Type 3/analysis
5.
Br J Cancer ; 100(12): 1957-65, 2009 Jun 16.
Article in English | MEDLINE | ID: mdl-19455146

ABSTRACT

The study shows constitutive activation of the Notch pathway in various types of malignancies. However, it remains unclear how the Notch pathway is involved in the pathogenesis of osteosarcoma. We investigated the expression of the Notch pathway molecules in osteosarcoma biopsy specimens and examined the effect of Notch pathway inhibition. Real-time PCR revealed overexpression of Notch2, Jagged1, HEY1, and HEY2. On the other hand, Notch1 and DLL1 were downregulated in biopsy specimens. Notch pathway inhibition using gamma-secretase inhibitor and CBF1 siRNA slowed the growth of osteosarcomas in vitro. In addition, gamma-secretase inhibitor-treated xenograft models exhibited significantly slower osteosarcoma growth. Cell cycle analysis revealed that gamma-secretase inhibitor promoted G1 arrest. Real-time PCR and western blot revealed that gamma-secretase inhibitor reduced the expression of accelerators of the cell cycle, including cyclin D1, cyclin E1, E2, and SKP2. On the other hand, p21(cip1) protein, a cell cycle suppressor, was upregulated by gamma-secretase inhibitor treatment. These findings suggest that inhibition of Notch pathway suppresses osteosarcoma growth by regulation of cell cycle regulator expression and that the inactivation of the Notch pathway may be a useful approach to the treatment of patients with osteosarcoma.


Subject(s)
Bone Neoplasms/prevention & control , Cell Cycle , Cell Proliferation , Osteosarcoma/prevention & control , Receptors, Notch/antagonists & inhibitors , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Amyloid Precursor Protein Secretases/genetics , Amyloid Precursor Protein Secretases/metabolism , Animals , Blotting, Western , Bone Neoplasms/metabolism , Bone Neoplasms/secondary , Bone and Bones/metabolism , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Humans , Immunoenzyme Techniques , Immunoglobulin J Recombination Signal Sequence-Binding Protein/antagonists & inhibitors , Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics , Immunoglobulin J Recombination Signal Sequence-Binding Protein/metabolism , Mice , Mice, Nude , Osteoblasts/cytology , Osteoblasts/metabolism , Osteosarcoma/metabolism , Osteosarcoma/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/pharmacology , Receptors, Notch/genetics , Receptors, Notch/metabolism , Reverse Transcriptase Polymerase Chain Reaction
6.
J Periodontal Res ; 43(1): 90-5, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18086166

ABSTRACT

BACKGROUND AND OBJECTIVE: Volatile sulfur compounds such as hydrogen sulfide (H(2)S) and methyl mercaptan (CH(3)SH) are the main causes of oral mal odor. However, the physiological functions of H(2)S have not been investigated in oral tissues. The aim of this study was to evaluate the effect of H(2)S on cell proliferation and the cell cycle in oral epithelial-like cells. MATERIAL AND METHODS: Ca9-22 cells were used in this study. Cells were cultured in 5% CO(2)/95% air with (5 or 10 ng/mL) or without H(2)S. DNA synthesis was measured using a 5-bromo-2-deoxyuridine enzyme-linked immunosorbent assay. The cell cycle was analyzed using a flow cytometer. The expressions of phosphorylated retinoblastoma protein (Rb), p21(Cip1) and p27(Kip1) were evaluated by western blotting. RESULTS: Exposure to 5 and 10 ng/mL of H(2)S significantly decreased DNA synthesis (p < 0.05). Cell cycle analysis also showed that exposure to both concentrations of H(2)S significantly increased the proportion of cells in G(1) phase (p < 0.001) and significantly decreased the proportion of cells in S phase (p < 0.01). Western blotting showed that Rb phosphorylation was reduced and p21(Cip1) was enhanced by exposure to H(2)S. CONCLUSION: The results indicated that H(2)S inhibits cell proliferation and induces cell cycle arrest via the expression of p21(Cip1) in Ca9-22 cells.


Subject(s)
Air Pollutants/pharmacology , Cell Proliferation/drug effects , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Epithelial Cells/drug effects , Gingiva/cytology , Hydrogen Sulfide/pharmacology , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Line , Cell Survival/drug effects , Cyclin-Dependent Kinase Inhibitor p21/drug effects , DNA/analysis , DNA/biosynthesis , Epithelial Cells/cytology , Gingiva/drug effects , Humans , L-Lactate Dehydrogenase/analysis
7.
Arch Oral Biol ; 47(9): 655-63, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12243969

ABSTRACT

Hepatocyte growth factor (HGF), also known as scatter factor, is a broad-spectrum and multifunctional cytokine required for the development, growth and regeneration of various organs and tissues. The expression of HGF in human gingival fibroblasts is induced by inflammatory cytokines such as interleukin 1. Thus, although it is possible that content of HGF in gingival crevicular fluid (GCF) in periodontitis is increased, this has not so far been reported because the volume of GCF is too small to determine HGF by the available enzyme-linked immunosorbent assay (ELISA). A recently developed, highly sensitive ELISA for HGF, with a detection limit of 1 pg/ml sample, has now enabled HGF to be measured in GCF.The mean HGF content in GCF from sites with clinically healthy gingiva, defined by the absence of overt signs of gingival inflammation and a probing depth (PD) <3 mm, was 1.7 ng/ml, and that of periodontitis, defined by obvious alveolar bone loss detected by radiographic examination and a PD> or =3 mm, was 3.23 ng/ml. Although treating the periodontitis did not significantly decrease the HGF concentration despite significantly improved clinical scores such as PD and Gingival Index, the total amount of HGF in GCF did decrease significantly after treatment. HGF was expressed by gingival fibroblasts and inflammatory cells as determined by in situ hybridization. HGF-activator (HGFA), which converts inactive pro-HGF to active mature HGF, was detected in gingival epithelial cells by immunostaining. The expression of HGFA was also confirmed in gingival tissue by reverse transcription-polymerase chain reaction (RT-PCR). These findings indicate that HGF is synthesized and activated in gingiva that is clinically healthy or associated with periodontitis.


Subject(s)
Gingival Crevicular Fluid/chemistry , Hepatocyte Growth Factor/analysis , Periodontitis/metabolism , Serine Endopeptidases/analysis , Adult , Aged , Case-Control Studies , Enzyme-Linked Immunosorbent Assay/methods , Female , Gene Expression , Hepatocyte Growth Factor/genetics , Humans , In Situ Hybridization , Male , Middle Aged , RNA/analysis , Reverse Transcriptase Polymerase Chain Reaction , Serine Endopeptidases/genetics
8.
Int Dent J ; 52 Suppl 3: 241-6, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12090461

ABSTRACT

AIM: Previous studies have demonstrated that methyl mercaptan (CH3SH), one of the main causes of oral malodour, might contribute to the initiation and progression of periodontal disease. These studies suggested that CH3SH may affect the epithelial cells of the gingival crevice, which form a barrier to the penetration of microbial substances. In this study, the effects of CH3SH on the epithelial cells and gingival fibroblasts were investigated. METHOD: Human oral epithelial carcinoma cell line (KB), human oral squamous cell carcinoma cell line (HSC-2), and human gingival fibroblasts (HGF) derived from healthy gingiva were used in this study. These cells were cultured in conditions of 5% CO2/95% air with or without CH3SH (10 ng/ml or 50 ng/ml) for 5 days. Cell numbers, proliferation and cytotoxicity were evaluated. RESULTS: CH3SH inhibited epithelial cell growth and proliferation at the concentration of 50 ng/ml, and a cytotoxic effect of CH3SH was also noted. On the other hand, HGF cells were not affected by 50 ng/ml CH3SH. CONCLUSION: High concentrations of CH3SH such as 50 ng/ml have an inhibitory effect on the growth and proliferation of epithelial cells, but not on those of fibroblasts.


Subject(s)
Gingiva/drug effects , Sulfhydryl Compounds/pharmacology , Analysis of Variance , Bromodeoxyuridine , Carcinoma, Squamous Cell/pathology , Cell Count , Cell Division/drug effects , Cell Survival , Cells, Cultured , Epithelial Cells/drug effects , Epithelial Cells/pathology , Fibroblasts/drug effects , Fibroblasts/pathology , Gingiva/pathology , Halitosis/metabolism , Humans , KB Cells/drug effects , KB Cells/pathology , L-Lactate Dehydrogenase/analysis , Statistics as Topic , Sulfhydryl Compounds/toxicity , Time Factors , Tumor Cells, Cultured
9.
Brain Res ; 921(1-2): 219-25, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11720729

ABSTRACT

It has been reported that bone morphogenetic proteins (BMPs) are involved in the generation of the central nervous system during development. However, the roles of BMPs in mature spinal cord have not been clarified. We examined the expression of BMP7 mRNA before and after traumatic injury of the adult rat spinal cord. BMP7 mRNA was already detectable at a relatively low level in uninjured spinal cord, but was dramatically increased after injury. Semiquantitative RT-PCR study further confirmed upregulation of BMP7 mRNA in injured spinal cord. In situ hybridization indicated that expression of BMP7 mRNA was present only in glial cells in uninjured spinal cord. After injury, the number of BMP7-expressing glial cells was increased, BMP7 expression also became apparent in motor neurons. It has been suggested that BMPs promote survival of subventricular zone cells in adult rats. Thus, our results suggest that increase in the expression of BMP7 promotes survival of neurons and glial cells after acute traumatic injury. In contrast, there is increasing evidence that BMPs inhibit neurogenesis and alternatively promote gliogenesis of neural progenitors, which are also present in adult spinal cord, suggesting that injury-upregulated BMP7 may regulate differentiation of glial cells from neural progenitors and may induce gliosis after central nervous system injury.


Subject(s)
Bone Morphogenetic Proteins/genetics , Neuroglia/metabolism , Neurons/metabolism , RNA, Messenger/metabolism , Spinal Cord Injuries/metabolism , Spinal Cord/metabolism , Transforming Growth Factor beta , Up-Regulation/genetics , Age Factors , Alternative Splicing/genetics , Animals , Bone Morphogenetic Protein 7 , Cell Division/genetics , Cell Survival/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Male , Nerve Regeneration/genetics , Neuroglia/cytology , Neurons/cytology , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Spinal Cord/cytology , Spinal Cord Injuries/genetics , Spinal Cord Injuries/physiopathology , Stem Cells/cytology , Stem Cells/metabolism
11.
Gut ; 48(5): 656-9, 2001 May.
Article in English | MEDLINE | ID: mdl-11302964

ABSTRACT

Biliary duct carcinomas (BDCs) are relatively rare and the carcinogenic mechanisms underlying their induction are poorly understood. There are two growth patterns, polypoid and non-polypoid infiltrative type, but little information is available concerning the relation between growth pattern and genetic alterations. A comparative study was therefore conducted to clarify if differences in genetic changes, including loss of heterozygosity (LOH) at 5q, 9p, 17p, and 18q, and K-ras mutations exist between polypoid and non-polypoid infiltrative type BDCs. LOH analysis was performed using microsatellite markers and K-ras point mutations were analysed by dot blot hybridisation. The incidences of changes for polypoid and non-polypoid infiltrative types were 73% and 26% on 5q, 63% and 59% on 9p, 55% and 50% on 17p, and 20% and 18% on 18q, and 25% and 27% for K-ras mutations. Most importantly, we found the frequency of 5qLOH to be significantly higher with polypoid growth than in the non-polypoid infiltrative type (p<0.05), especially in extrahepatic duct carcinomas (p<0.05). The incidences of other genetic alterations (LOH at 9p, 17p, and 18q, and K-ras mutations) showed similar rates with both tumour types. The present data suggest that 5qLOH may have a close relation with polypoid growth in BDCs.


Subject(s)
Bile Duct Neoplasms/genetics , Bile Ducts, Extrahepatic , Bile Ducts, Intrahepatic , Carcinoma/genetics , Chromosomes, Human, Pair 5/genetics , Adult , Aged , Aged, 80 and over , Electrophoresis, Polyacrylamide Gel , Female , Genes, APC/genetics , Genes, Tumor Suppressor/genetics , Genes, p16/genetics , Genes, p53/genetics , Genes, ras/genetics , Humans , Loss of Heterozygosity/genetics , Male , Microsatellite Repeats , Middle Aged , Point Mutation/genetics , Polymerase Chain Reaction
12.
J Bone Miner Res ; 16(1): 57-62, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11149490

ABSTRACT

An accurate assay method of 25-hydroxyvitamin D3 24-hydroxylase (24-hydroxylase) was established. Kidney mitochondria prepared from vitamin D-replete rats were treated with polyoxyethylenesorbitan monolaurate. The solubilized suspension was ultracentrifuged at 100,000g for 60 minutes and an aliquot of the supernatant was incubated under the saturating concentrations of substrate NADPH and the mitochondrial-type electron transferring proteins, adrenodoxin and NADPH-adrenodoxin reductase. Products were analyzed by high-performance liquid chromatography (HPLC) monitoring effluents at a wavelength of 265 nm. The maximal velocity of the enzyme in vitamin D-replete rats was 400 pmol/minute per mg of protein, which was considerably higher than those reported by previous authors who used intact kidney mitochondria as the enzyme source. In applying the new assay method, an interesting property was found; Michaelis constant of 24-hydroxylase for 25-hydroxyvitamin D3 [25(OH)D3] was 0.6 microM, which was 35-fold lower than that for 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] which was 20.9 microM. This fact indicates that affinity of the enzyme to 25(OH)D3 is 35-fold higher than that to 1alpha,25(OH)2D3. These data suggest that 25(OH)D3 is the preferred substrate to 1alpha,25(OH)2D3.


Subject(s)
25-Hydroxyvitamin D3 1-alpha-Hydroxylase/metabolism , Calcifediol/metabolism , Calcitriol/metabolism , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/analysis , Adrenodoxin/metabolism , Animals , Chromatography, High Pressure Liquid , Ferredoxin-NADP Reductase/metabolism , Hydrogen-Ion Concentration , Kidney/enzymology , Kidney/metabolism , Kinetics , Male , Mitochondria/enzymology , Mitochondria/metabolism , Polysorbates/pharmacology , Rats , Rats, Sprague-Dawley , Temperature
13.
Adv Drug Deliv Rev ; 45(1): 57-64, 2000 Dec 06.
Article in English | MEDLINE | ID: mdl-11104897

ABSTRACT

Iodinated poppy-seed oil (IPSO) accumulates selectively in hepatocellular carcinoma (HCC) when injected into the hepatic artery. This virtue has been applied to the hepatic arterial injection chemotherapy for the disease. We invented a new water-in-oil-in-water emulsion (W/O/W), in which IPSO microdroplets, 70 micrometer in diameter, were suspended in physiological saline enclosing numerous vesicles of an aqueous solution of epirubicin with remarkable stability. After hepatic arterial injection, the microdroplets accumulated only in HCC tissue and remained in the tissue for more than 3 weeks affecting tumor cells. Efficacy of the W/O/W has been fully proved clinically; the 6-year cumulative survival rate for 24 patients bearing HCC nodules recurrent after hepatectomy, including even 12 patients with four or more nodules, though prognosis of these patients is recognized very poor, was 24%.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Carcinoma, Hepatocellular/drug therapy , Epirubicin/administration & dosage , Liver Neoplasms/drug therapy , Aged , Emulsions , Epirubicin/blood , Hepatic Artery , Humans , Injections, Intra-Arterial , Male , Middle Aged , Particle Size
14.
Eur J Gastroenterol Hepatol ; 12(3): 305-12, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10750651

ABSTRACT

OBJECTIVE: Until now, radiopaque gallstones have been excluded from extracorporeal shock wave lithotripsy (ESWL), because these stones in vivo are less sensitive to the forces that cause disintegration. In Japan there is a higher percentage of patients with radiopaque gallstones than in Western countries. Our purpose in working with patients in Japan was to warrant extensive indication of ESWL to radiopaque gallstones, especially densely calcified stones. DESIGN/METHODS: Retrospective analysis of clinical data. Patients were classified by computed tomography (CT) of stones. Group A consisted of 78 patients whose gallstones were densely calcified (CT attenuation values in Hounsfield units (HU), 473 +/- 323). Group B consisted of 22 patients whose stones had a calcified rim (CT attenuation values, 357 +/- 244). Ninety-eight patients received adjuvant dissolution therapy with ursodeoxycholic acid. Other recommendations, such as a glass of milk at night, were not given to the patients. SETTING: One university hospital and one general hospital. PATIENTS: One hundred consecutive Japanese patients with radiopaque stones in contractile gallbladder (CT attenuation values, > 150 HU, 447 +/- 310, mean +/- SD) were the subjects. With respect to the efficacy of ESWL, a degree of calcification for stones and its relationship with the rates of stone fragmentation and disappearance were assessed. Fragmentation to less than 3 mm in stone diameter was the aim, without limit of shock wave discharges and sessions. RESULTS: After ESWL sessions stones were fragmented successfully in 74 of the 100 patients (57 of the 78 patients in Group A, and 17 of the 22 patients in Group B). The mean number of discharges per patient was 10,435 +/- 8,726. The mean number of discharges for successful stone fragmentation of Group A (9,839 +/- 8,187) was not significantly different from that of Group B (11,376 +/- 6,344). One year after lithotripsy, 60 of the 100 patients were free of stones (45 in Group A, and 15 in Group B). CONCLUSION: It appears that patients with either densely calcified gallstones, or those in whom the stones have a calcified rim, are both suitable candidates for lithotripsy.


Subject(s)
Cholelithiasis/therapy , Lithotripsy/methods , Adult , Aged , Aged, 80 and over , Calcinosis , Cholelithiasis/chemistry , Cholelithiasis/diagnosis , Cholelithiasis/diagnostic imaging , Cost of Illness , Female , Humans , Japan , Male , Middle Aged , Retrospective Studies , Risk Factors , Tomography, X-Ray Computed , Ursodeoxycholic Acid/therapeutic use
15.
Cancer Res ; 60(3): 522-4, 2000 Feb 01.
Article in English | MEDLINE | ID: mdl-10676628

ABSTRACT

The frequency of K-ras mutation in biliary duct carcinomas in different locations and the relationship to the form of the junction of the pancreaticobiliary duct (JPBD) are not understood clearly. These points were investigated in the present study. Thirty-seven biliary duct carcinomas in patients without anomalous JPBD were investigated for K-ras mutations. Regarding location, 12 were hilar, 4 in the upper, 11 in the middle, and 10 in the lower portion of the duct. Furthermore, with 14 cases for which the form of the JPBD could be confirmed by endoscopic retrograde cholangiopancreatography or postoperative cholangiopancreatography, division was made into two types: those with a long common channel (>5 mm) in the papilla of Vater (type 1, n = 4), and the other with a shorter or nonapparent common channel (type 2, n = 10). The overall frequency of K-ras mutation was 30%, the incidence gradually increasing from upper to lower regions. K-ras mutations were significantly more frequent in biliary duct carcinomas associated with long common channels (P < 0.05). These results suggest that a long common channel may bear a relation to K-ras mutations in biliary duct carcinogenesis, presumably through its influence on pancreatic juice regurgitation.


Subject(s)
Bile Duct Neoplasms/genetics , Bile Ducts/abnormalities , Genes, ras , Mutation , Pancreatic Ducts/abnormalities , Humans
16.
Am J Phys Anthropol ; 111(2): 263-81, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10640951

ABSTRACT

Branisella boliviana, from the Late Oligocene of Salla, Bolivia, is the oldest fossil platyrrhine monkey discovered. To date, several fossil specimens of Branisella have been obtained, but most of them are fragmentary dentitions, so the animals craniodental morphology is still obscure. During the 1996 field season a pair of upper and lower jaw fragments and another nearly complete mandible were recovered. These new fossil materials reveal the following morphological features in Branisella: 1) P(2) is much smaller than P(3,4), whereas P(2) is relatively small but probably sexually dimorphic; 2) the zygomatic arch protrudes smoothly posterolaterally from the maxillary bone, as in extant Callicebus; 3) the mandibular arcade is nearly V-shaped and the symphysial angle, which is formed by the horizontal plane and the anterior face of mandibular symphysis, is about 40 degrees, i.e., it neither leans as far anteriorly as in callitrichines nor does it stand as vertically as Cebus; 4) upper and lower molars wore down rapidly in life, suggesting a herbivorous diet and the possibility of terrestriality; and 5) dental eruptive sequence is the same as in extant Aotus. As a whole, the dentition of Branisella is very similar to that of Proteopithecus from the Late Eocene of Fayum, Egypt, except in the lower canine morphology, suggesting a close phyletic relationship between them. The origin and early diversification of platyrrhine monkeys might have occurred on the African continent before crossing the Atlantic Ocean.


Subject(s)
Biological Evolution , Cebidae/anatomy & histology , Dentition , Phylogeny , Animals , Biometry , Cebidae/genetics , Diet , Fossils
17.
Biol Chem ; 381(12): 1149-53, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11209749

ABSTRACT

Circadian rhythms of important enzymes involved in the conversion of cholesterol to bile acids [sterol 12alpha-hydroxylase (12alpha-hydroxylase) and cholesterol 7alpha-hydroxylase (7alpha-hydroxylase)] and an albumin site D-binding protein (DBP) were examined in rats. When the animals were fed freely, they usually ate in the dark and the circadian rhythms of activities of 12alpha-hydroxylase and 7alpha-hydroxylase showed the same peaks (at 10 p.m.) and lows (at 2 p.m.). Their mRNA levels were determined at four timepoints: 3 a.m., 10 a.m., 3 p.m. and 10 p.m. A maximum of the rhythm of 12alpha-hydroxylase was observed at 3 p.m. and the minimum at 3 a.m. These results are distinct from those of 7alpha-hydroxylase, whose maximum point was at 10 p.m. and minimum at 3 p.m. When the rats were fed only in the day-time (from 9 a.m. to 5 p.m.), a marked shift of the activity and mRNA rhythms was observed with both enzymes. The circadian rhythms of the activities of both enzymes showed the same peaks (at 3 p.m.), but the mRNA levels of 12alpha-hydroxylase were distinct from those of 7alpha-hydroxylase, whose maximum point was at 3 a.m. and minimum at 10 p.m. Differences between the maximum and the minimum points of each enzyme mRNA level were statistically significant (P < 0.01 for 12alpha-hydroxylase and 0.05 for 7alpha-hydroxylase). Moreover, circadian rhythms of DBP were also markedly shifted with the change of feeding period. The maximum mRNA level was observed at 10 p.m. instead of 10 a.m. and the minimum was at 10 a.m. instead of 10 p.m.


Subject(s)
Cholesterol/metabolism , Circadian Rhythm/physiology , DNA-Binding Proteins , Rats/metabolism , Steroid Hydroxylases/metabolism , Transcription Factors/metabolism , Animals , Cholesterol/genetics , Cholesterol/physiology , Cholesterol 7-alpha-Hydroxylase/genetics , Cholesterol 7-alpha-Hydroxylase/metabolism , Cholesterol 7-alpha-Hydroxylase/physiology , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Cytochrome P-450 Enzyme System/physiology , Feeding Behavior/physiology , Male , RNA, Messenger/metabolism , Rats/physiology , Rats, Wistar , Steroid 12-alpha-Hydroxylase , Steroid Hydroxylases/genetics , Steroid Hydroxylases/physiology , Transcription Factors/genetics , Transcription Factors/physiology
18.
Clin Exp Metastasis ; 18(7): 561-71, 2000.
Article in English | MEDLINE | ID: mdl-11688961

ABSTRACT

Cell lines with high metastatic capacity to the lung were established by sequential passage of a human pancreatic cancer cell line (SUIT-2) through the lung of a nude mouse, via the lateral tail vein and from a subcutaneous inoculum. Cells of the parental SUIT-2 and sublines S2-VPx (x-cycle selection from SUIT-2 cells, by Vein-Pulmonary metastasis-culture) and S2-CPx (x-cycle selection, by Cutis-Pulmonary metastasis-culture) were injected intravenously or subcutaneously into nude mice to produce experimental or spontaneous lung metastasis. The S2-VP10 cell line produced pulmonary metastases in 100% of the nude mice, when injected intravenously. It failed, however, to produce more lung colonies than its parent cell line, when injected subcutaneously. The S2-CP8 cell line produced extensive pulmonary metastases in 100% of the nude mice, when injected either intravenously or subcutaneously. This study indicates that the nude mouse provided a good model for in vivo selection of metastatic cells from SUIT-2 cells both experimentally and spontaneously, and that the SUIT-2, S2-VPx, and S2-CPx cell lines will be valuable in the study of human cancer metastasis. We previously reported high levels of ezrin expression in the S2-VP10 and S2-CP8 cell lines. Here we show that these cell lines exhibit a greater capacity to invade or attach to various extracellular matrix components than the parent SUIT-2 cells. The S2-CP8 cell lines also exhibit greater level of type-I and type-IV collagen-degrading activity than the parent SUIT-2 cell line and the S2-VP10 cell line, which shows similar collagen-degrading activity to the parent SUIT-2 cells. In RT-PCR studies, SUIT-2, S2-CP8 and S2-VP10 cell lines constitutively expressed many matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP7, MMP-9, MMP-10 and MMP-14). These results suggest that some parameters that enhance adhesion and invasion are important to both experimental and spontaneous metastasis and the collagen degrading enzymes are predicted to play a key-role during spontaneous metastasis.


Subject(s)
Collagen/metabolism , Lung Neoplasms/secondary , Pancreatic Neoplasms/enzymology , Animals , Cell Adhesion , Cell Division , Collagen Type I/metabolism , Collagen Type IV/metabolism , Female , Humans , Kinetics , Matrix Metalloproteinases/biosynthesis , Matrix Metalloproteinases/genetics , Mice , Mice, Nude , Neoplasm Invasiveness , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Tissue Inhibitor of Metalloproteinases/biosynthesis , Tissue Inhibitor of Metalloproteinases/genetics , Tumor Cells, Cultured
19.
J Lipid Res ; 40(10): 1793-8, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10508198

ABSTRACT

Hepatocyte-like cells have been observed in the pancreas of the rat. We examined the bile acid biosynthetic function of these cells to determine whether they were real hepatocytes. This study investigated the existence of two liver-specific enzymes involved in bile acid biosynthesis (cholesterol 7alpha-hydroxylase and delta(4)-3-ketosteroid 5beta-reductase) in the hepatocyte-like cells. We could demonstrate cholesterol 7alpha-hydroxylase activity and its circadian rhythm in the hepatocyte-like cells. Northern blot analysis demonstrated the expression of messenger RNA for the 7alpha-hydroxylase and delta(4)-3-ketosteroid 5beta-reductase in the pancreatic hepatocyte-like cells. To measure the amount of the messenger RNA, we used the competitive polymerase chain reaction method for the 7alpha-hydroxylase. This quantitation revealed the existence of a circadian rhythm of cholesterol 7alpha-hydroxylase messenger RNA in the hepatocyte-like cells. These results indicated that bile acid biosynthesis was performed in the pancreatic hepatocyte-like cells as noted as in the liver parenchymal cells.


Subject(s)
Cholesterol 7-alpha-Hydroxylase/genetics , Circadian Rhythm , Gene Expression Regulation, Enzymologic , Liver/enzymology , Microsomes/enzymology , Oxidoreductases/genetics , Pancreas/enzymology , Animals , Cholesterol 7-alpha-Hydroxylase/metabolism , Kinetics , Liver/cytology , Male , Microsomes, Liver/enzymology , Oxidoreductases/metabolism , Pancreas/cytology , RNA, Messenger/genetics , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction , Transcription, Genetic
20.
J Cancer Res Clin Oncol ; 125(8-9): 439-43, 1999.
Article in English | MEDLINE | ID: mdl-10480335

ABSTRACT

PURPOSE: This present study aimed to investigate the genetic changes in gallbladder carcinogenesis. METHODS: Eleven intramucosal gallbladder carcinomas were compared with 31 invasive lesions for loss of heterozygosity (LOH) on chromosomes 5q, 9p, 17p and 18q, frame-shift mutations in a ten-adenine repeat site within the gene encoding the transforming growth factor beta type II receptor (TGFbetaRII) and an eight-guanine repeat site within BAX, and point mutations in codon 12 of Ki-ras. RESULTS: The incidences of LOH in intramucosal and invasive carcinomas were 14% and 17% on 5q, 9% and 52% on 9p, 64% and 65% on 17p, and 13% and 32% on 18q. No frame-shift mutations were found at TGFbetaRII or BAX, and point mutations in codon 12 of Ki-ras were present in only 8% of the samples. Thus, LOH on 17p was by far the most frequent lesion with similar results in both intramucosal and invasive carcinomas. In contrast, the frequency of LOH on 9p and 18q was distinctly higher in invasive lesions. CONCLUSION: The present data suggest that LOH on 17p may play an important role in the evolution of gallbladder carcinoma from a relatively early phase, while LOH on 9p and 18q may play roles in progression.


Subject(s)
Carcinoma/genetics , Chromosomes, Human, Pair 17/genetics , Chromosomes, Human, Pair 18/genetics , Chromosomes, Human, Pair 5/genetics , Chromosomes, Human, Pair 9/genetics , Frameshift Mutation , Gallbladder Neoplasms/genetics , Genes, ras/genetics , Loss of Heterozygosity , Proto-Oncogene Proteins c-bcl-2 , Proto-Oncogene Proteins/genetics , Receptors, Transforming Growth Factor beta/genetics , ras Proteins/genetics , Adenine/metabolism , Adenocarcinoma/genetics , Aged , Aged, 80 and over , Carcinoma/pathology , Carcinoma, Small Cell/genetics , Carcinoma, Squamous Cell/genetics , Female , Gallbladder Neoplasms/pathology , Guanine/metabolism , Humans , Male , Microsatellite Repeats , Middle Aged , Neoplasm Invasiveness , Polymerase Chain Reaction/methods , Protein Serine-Threonine Kinases , Receptor, Transforming Growth Factor-beta Type II , bcl-2-Associated X Protein
SELECTION OF CITATIONS
SEARCH DETAIL